{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:01Z","timestamp":1787022841862,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1532\/ijh97.06033","type":"journal-article","created":{"date-parts":[[2006,7,28]],"date-time":"2006-07-28T13:27:09Z","timestamp":1154093229000},"page":"74-78","source":"Crossref","is-referenced-by-count":13,"title":["Leukemic and Meningeal Relapse of CD5 + Intravascular Large B-Cell Lymphoma with Down-Modulation of CD20 after Rituximab Therapy"],"prefix":"10.1007","volume":"84","author":[{"given":"Tatsuharu","family":"Ohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisaki","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Hishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigefusa","family":"Hada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Wick MR, Mills SE. Intravascular lymphomatosis: clinicopathologic features and differential diagnosis. Semin Diagn Pathol.<\/i> 1991; 8:91-101."},{"key":"E00002","unstructured":"Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis: a systemic disease with neurologic manifestations. Cancer.<\/i> 1993; 71:3156-3164."},{"key":"E00003","unstructured":"DiGiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol.<\/i> 1994; 12:2573-2579."},{"key":"E00004","unstructured":"Yamaguchi M, Ohno T, Oka K, et al. De novo CD5+ diffuse large B-cell lymphoma: clinicopathologic study of 109 patients. Blood.<\/i> 2002;99:815-821."},{"key":"E00005","unstructured":"Murase T, Nakamura S, Kawaguchi, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with hemophagocytic syndrome. Br J Haematol.<\/i> 2000;111:826-834."},{"key":"E00006","unstructured":"Kennedy GA, Tey SK, Cobcroft R, et al. Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review. Br J Haematol.<\/i> 2002;119:412-416."},{"key":"E00007","unstructured":"Chu PG, Chen YY, Molina A, Arber DA, Weiss LM. Recurrent B-cell neoplasms after rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma.<\/i> 2002;43:2335-2341."},{"key":"E00008","unstructured":"Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol.<\/i> 1993;169:291-295."},{"key":"E00009","unstructured":"Ohno T, Miyake N, Hada S, et al. Hemophagocytic syndrome in five patients with Epstein-Barr virus-negative B-cell lymphoma. Cancer.<\/i> 1998;82:1963-1972."},{"key":"E00010","unstructured":"Ito M, Kim Y, Choi JW, Ozawa H, Fujino M. Prevalence of intravascular B-cell lymphoma with bone marrow involvement at initial presentation. Int J Hematol.<\/i> 2003;77:159-163."},{"key":"E00011","unstructured":"Ohno T, Ueda Y, Nagai K, et al. The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell\/natural killer cell lymphomas. Int J Hematol.<\/i> 2003;77:286-294."},{"key":"E00012","unstructured":"Khoury H, Dalal BI, Nantel SH. Intravascular lymphoma presenting with bone marrow involvement and leukemic phase. Leuk Lymphoma.<\/i> 2003;44:1043-1047."},{"key":"E00013","unstructured":"Ponzoni M, Arrigoni G, Gould VE, et al. Lack of CD29 (\u03b21 integrin) and CD54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol.<\/i> 2000;31:220-226."},{"key":"E00014","unstructured":"Kobayashi T, Yamaguchi T, Kim S, et al. Microarray reveals differences in both tumors and vascular specific gene expression in de novo<\/i> CD5+ and CD5- diffuse large B-cell lymphomas. Cancer Res.<\/i> 2003;63:60-66."},{"key":"E00015","unstructured":"Carter DK, Batts KP, de Groen PC, Kurtin PJ. Angiotropic large cell lymphoma (intravascular lymphomatosis) occurring after follicular small cleaved cell lymphoma. Mayo Clin Proc.<\/i> 1996;71:869-873."},{"key":"E00016","unstructured":"Berinstein NL, Grillo-L\u00f3pez AJ, White CA, et al. Association of serum rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol.<\/i> 1998;9:995-1001."},{"key":"E00017","unstructured":"Igarashi T, Kobayashi Y, Ogura M, et al. Factors affecting toxicity, response, and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol.<\/i> 2002;13:928-943."},{"key":"E00018","unstructured":"Hariunpaa A, Wiklund T, Collan J, et al. Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma. Leuk Lymphoma.<\/i> 2001;42:731-738."},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"McLaughlin P. Rituximab: perspective on single agent experience, and future directions in combination trials. Crit Rev Oncol Hematol.<\/i>2001;40:3-16.","DOI":"10.1016\/S1040-8428(01)00130-5"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T05:23:01Z","timestamp":1555737781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["40R7743014478175"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06033","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7,1]]}}}